Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128002631 | 12800263 | 1 | I | 20160927 | 20160930 | 20160930 | EXP | BR-009507513-1609BRA014698 | MERCK | 0.00 | F | Y | 77.00000 | KG | 20160930 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128002631 | 12800263 | 1 | PS | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 50 (UNITS NOT PROVIDED), BID | 20386 | TABLET | BID | ||||||||
| 128002631 | 12800263 | 2 | C | GLIFAGE XR | METFORMIN HYDROCHLORIDE | 1 | 2 DF, QD | 0 | 2 | DF | QD | ||||||||
| 128002631 | 12800263 | 3 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 75 MICROGRAM, QD | 0 | 75 | UG | QD | ||||||||
| 128002631 | 12800263 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 128002631 | 12800263 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 128002631 | 12800263 | Breast cancer | |
| 128002631 | 12800263 | Diabetes mellitus | |
| 128002631 | 12800263 | Hypercholesterolaemia | |
| 128002631 | 12800263 | Hypothyroidism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |